236 related articles for article (PubMed ID: 19585648)
1. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
2. Identification of TRIM22 as a RING finger E3 ubiquitin ligase.
Duan Z; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2008 Sep; 374(3):502-6. PubMed ID: 18656448
[TBL] [Abstract][Full Text] [Related]
3. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
4. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E
J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
6. Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of
Lim KH; Park ES; Kim DH; Cho KC; Kim KP; Park YK; Ahn SH; Park SH; Kim KH; Kim CW; Kang HS; Lee AR; Park S; Sim H; Won J; Seok K; You JS; Lee JH; Yi NJ; Lee KW; Suh KS; Seong BL; Kim KH
Gut; 2018 Jan; 67(1):166-178. PubMed ID: 28341749
[TBL] [Abstract][Full Text] [Related]
7. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
8. A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1.
Gao B; Wang Y; Xu W; Duan Z; Xiong S
J Immunol; 2010 Aug; 185(4):2314-23. PubMed ID: 20631312
[TBL] [Abstract][Full Text] [Related]
9. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
10. B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies.
Sivaramakrishnan G; Sun Y; Rajmohan R; Lin VC
FEBS Lett; 2009 Jun; 583(12):2093-9. PubMed ID: 19481078
[TBL] [Abstract][Full Text] [Related]
11. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
12. SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity.
Yang H; Zhou Y; Mo J; Xiang Q; Qin M; Liu W; Shang J; Yang Q; Xu W; Yang G; Tan Q; Wu K; Liu Y; Wu J
Antiviral Res; 2020 May; 177():104761. PubMed ID: 32147495
[TBL] [Abstract][Full Text] [Related]
13. TRIM22. A Multitasking Antiviral Factor.
Pagani I; Poli G; Vicenzi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440633
[TBL] [Abstract][Full Text] [Related]
14. The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase.
Petersson J; Lönnbro P; Herr AM; Mörgelin M; Gullberg U; Drott K
Exp Cell Res; 2010 Feb; 316(4):568-79. PubMed ID: 20006605
[TBL] [Abstract][Full Text] [Related]
15. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
Won J; Kang HS; Kim NY; Dezhbord M; Marakkalage KG; Lee E-H; Lee D; Park S; Kim D-S; Kim K-H
J Virol; 2024 Jun; 98(6):e0046824. PubMed ID: 38780244
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction.
Sun Y; Ho GH; Koong HN; Sivaramakrishnan G; Ang WT; Koh QM; Lin VC
Biochem Biophys Res Commun; 2013 Nov; 441(3):600-6. PubMed ID: 24183724
[TBL] [Abstract][Full Text] [Related]
18. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.
Eldin P; Papon L; Oteiza A; Brocchi E; Lawson TG; Mechti N
J Gen Virol; 2009 Mar; 90(Pt 3):536-545. PubMed ID: 19218198
[TBL] [Abstract][Full Text] [Related]
19. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
Liu T; Cong M; Wang P; Jia J; Liu Y; Hermonat PL; You H
Biochem Biophys Res Commun; 2009 Jul; 385(1):106-11. PubMed ID: 19410559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
